Therapeutic effects of inulin-type oligosaccharides of Morinda officinalis on Streptococcus pneumoniae meningitis in mice.
10.12122/j.issn.1673-4254.2025.03.15
- Author:
Zehan LI
1
;
Meng LIANG
2
;
Gencheng HAN
2
;
Xuewu ZHANG
1
Author Information
1. College of Medicine, Yanbian University, Yanji 133002, China.
2. Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100850, China.
- Publication Type:Journal Article
- Keywords:
Streptococcus pneumoniae;
blood-brain barrier;
interferon-γ;
inulin-type oligosaccharides of Morinda officinalis;
meningitis
- MeSH:
Animals;
Morinda/chemistry*;
Mice, Inbred C57BL;
Male;
Mice;
Meningitis, Pneumococcal/drug therapy*;
Blood-Brain Barrier/metabolism*;
Inulin/therapeutic use*;
Oligosaccharides/therapeutic use*;
Disease Models, Animal;
Interferon-gamma/metabolism*;
Brain Edema
- From:
Journal of Southern Medical University
2025;45(3):577-586
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the therapeutic effects of inulin-type oligosaccharides of Morinda officinalis (IOMO) in a murine model of Streptococcus pneumoniae meningitis (SPM) and explore its possible mechanisms.
METHODS:A total of 120 male C57BL/6J mice were randomly assigned into Sham, SPM+Saline, SPM+IOMO (25 mg/kg), and SPM+IOMO (50 mg/kg) groups. After modeling, the mice received daily gavage of saline or IOMO at the indicated doses for 7 consecutive days, and the changes in symptom scores and mortality of the mice were monitored. Brain pathology and neuronal injury of the mice were assessed using HE and Nissl staining, and qRT-PCR was performed to detect mRNA levels of the inflammatory mediators. Brain edema and blood-brain barrier (BBB) permeability of the mice were evaluated by measuring brain water content and Evans blue (EB) staining; Western blotting was used to analyze the expressions of BBB-associated proteins, and flow cytometry was employed to detect IFN‑γ expression level in the infiltrating lymphocytes. Open-field test (OFT) and novel object recognition test (NORT) were conducted to assess learning and memory ability of the mice on day 21 after modeling.
RESULTS:IOMO treatment at 50 mg/kg significantly reduced the symptom scores and mortality rate of SPM mice, alleviated brain damage, and downregulated mRNA levels of IL-6, TNF‑α, IL-1β, IL-18, IFN‑γ, iNOS, NLRP3, ASC, caspase-1 and GSDMD in the brain tissue. IOMO treatment also decreased brain water content and EB leakage, upregulated VE-cadherin and occludin expressions, and suppressed AQP4, iNOS, and IFN‑γ levels of the mice. IOMO-treated mice exhibited improved learning and memory compared with the saline-treated mice on day 21 after SPM modeling.
CONCLUSIONS:IOMO alleviates SPM symptoms, reduces mortality, and mitigates cognitive deficits in mice possibly by suppressing cerebral inflammation and protecting BBB functions.
